Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: JIANGXI BIO(06915) the Revenue is 48.06 M (-11.91%);the EBIT is 14.88 M (-32.6%);the EPS is 0.0289 (-61.05%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.05B11.91%
----
----
EBIT
0.01B32.60%
----
----
EPS
0.028961.05%
----
----
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf